Privia Health Group Forecast, price target & analysts
Privia Health Group Target price 2025 - Analyst rating & recommendation
Privia Health Group Classifications & Recommendation:
Privia Health Group Price Target
| Target Price | $27.48 |
| Price | $25.46 |
| Potential |
7.92%
register free of charge
|
| Number of Estimates | 21 |
|
21 Analysts have issued a price target Privia Health Group 2026 .
The average Privia Health Group target price is $27.48.
This is
7.92%
register free of charge
$35.00
37.47%
register free of charge
$21.00
17.52%
register free of charge
|
|
| A rating was issued by 22 analysts: 21 Analysts recommend Privia Health Group to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Privia Health Group stock has an average upside potential 2026 of
7.92%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2029
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Billion $ | 1.66 | 1.70 |
| 22.19% | 2.39% | |
| EBITDA Margin | 1.64% | 5.25% |
| 252.88% | 220.20% | |
| Net Margin | 1.37% | 0.92% |
| 294.37% | 33.08% |
21 Analysts have issued a sales forecast Privia Health Group 2024 . The average Privia Health Group sales estimate is
This results in the following potential growth metrics:
22 Analysts have issued an Privia Health Group EBITDA forecast 2024. The average Privia Health Group EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
15 Privia Health Group Analysts have issued a net profit forecast 2024. The average Privia Health Group net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2029
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.19 | 0.13 |
| 337.50% | 31.58% | |
| P/E | 184.23 | |
| EV/Sales | 1.48 |
15 Analysts have issued a Privia Health Group forecast for earnings per share. The average Privia Health Group <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Privia Health Group stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Privia Health Group...
Current Privia Health Group Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JMP Securities | Locked ➜ Locked | Locked | Feb 14 2025 |
| Needham | Locked ➜ Locked | Locked | Jan 15 2025 |
| Needham | Locked ➜ Locked | Locked | Jan 10 2025 |
| Stephens & Co. | Locked ➜ Locked | Locked | Jan 07 2025 |
| Stephens & Co. | Locked ➜ Locked | Locked | Jan 02 2025 |
| Macquarie | Locked ➜ Locked | Locked | Dec 16 2024 |
| JP Morgan | Locked ➜ Locked | Locked | Nov 29 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
JMP Securities: Locked ➜ Locked
|
Feb 14 2025 |
|
Locked
Needham: Locked ➜ Locked
|
Jan 15 2025 |
|
Locked
Needham: Locked ➜ Locked
|
Jan 10 2025 |
|
Locked
Stephens & Co.: Locked ➜ Locked
|
Jan 07 2025 |
|
Locked
Stephens & Co.: Locked ➜ Locked
|
Jan 02 2025 |
|
Locked
Macquarie: Locked ➜ Locked
|
Dec 16 2024 |
|
Locked
JP Morgan: Locked ➜ Locked
|
Nov 29 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
